• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $MEDS

    TRxADE HEALTH Inc.

    Subscribe to $MEDS
    $MEDS
    Other Pharmaceuticals
    Health Care

    TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.

    IPO Year:

    Exchange: NASDAQ

    Website: trxadegroup.com

    Recent Analyst Ratings for TRxADE HEALTH Inc.

    DatePrice TargetRatingAnalyst
    12/9/2021$4.50Buy
    EF Hutton
    See more ratings

    TRxADE HEALTH Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • EF Hutton initiated coverage on Trxade Health with a new price target

      EF Hutton initiated coverage of Trxade Health with a rating of Buy and set a new price target of $4.50

      12/9/21 9:10:50 AM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • Maxim Group initiated coverage on Trxade Group

      Maxim Group initiated coverage of Trxade Group with a rating of Buy

      2/26/21 8:08:35 AM ET
      $MEDS
      Other Pharmaceuticals
      Health Care

    TRxADE HEALTH Inc. SEC Filings

    See more
    • TRxADE HEALTH Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Scienture Holdings, Inc. (0001382574) (Filer)

      9/24/24 4:05:38 PM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • SEC Form DEF 14C filed by TRxADE HEALTH Inc.

      DEF 14C - TRxADE HEALTH, INC (0001382574) (Filer)

      8/28/24 4:05:30 PM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • SEC Form PRE 14C filed by TRxADE HEALTH Inc.

      PRE 14C - TRxADE HEALTH, INC (0001382574) (Filer)

      8/15/24 9:57:20 PM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • SEC Form 10-Q filed by TRxADE HEALTH Inc.

      10-Q - TRxADE HEALTH, INC (0001382574) (Filer)

      8/9/24 4:05:54 PM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • TRxADE HEALTH Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - TRxADE HEALTH, INC (0001382574) (Filer)

      7/31/24 5:25:43 PM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • TRxADE HEALTH Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - TRxADE HEALTH, INC (0001382574) (Filer)

      7/9/24 8:05:39 AM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • SEC Form 10-Q filed by TRxADE HEALTH Inc.

      10-Q - TRxADE HEALTH, INC (0001382574) (Filer)

      6/26/24 9:50:33 AM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • TRxADE HEALTH Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - TRxADE HEALTH, INC (0001382574) (Filer)

      6/20/24 8:00:24 AM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • TRxADE HEALTH Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - TRxADE HEALTH, INC (0001382574) (Filer)

      5/30/24 4:05:38 PM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • TRxADE HEALTH Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - TRxADE HEALTH, INC (0001382574) (Filer)

      5/23/24 5:00:16 PM ET
      $MEDS
      Other Pharmaceuticals
      Health Care

    TRxADE HEALTH Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Shankar Hariharan claimed ownership of 97,087 shares (SEC Form 3)

      3 - TRxADE HEALTH, INC (0001382574) (Issuer)

      8/5/24 9:23:01 PM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • New insider Narasimhan Mani claimed ownership of 57,977 shares (SEC Form 3)

      3 - TRxADE HEALTH, INC (0001382574) (Issuer)

      8/5/24 9:23:00 PM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • Ajjarapu Surendra K was granted 10,000 shares (SEC Form 4) (Amendment)

      4/A - TRxADE HEALTH, INC (0001382574) (Issuer)

      5/28/24 5:01:21 PM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • Patel Prashant was granted 10,000 shares (SEC Form 4) (Amendment)

      4/A - TRxADE HEALTH, INC (0001382574) (Issuer)

      5/28/24 4:59:50 PM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • Ajjarapu Surendra K was granted 150,000 shares (SEC Form 4)

      4 - TRxADE HEALTH, INC (0001382574) (Issuer)

      1/16/24 6:10:35 AM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • Patel Prashant was granted 150,000 shares (SEC Form 4)

      4 - TRxADE HEALTH, INC (0001382574) (Issuer)

      1/16/24 6:12:50 AM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • SEC Form 4: Huffman Janet was granted 50,000 shares, increasing direct ownership by 232% to 71,551 units

      4 - TRxADE HEALTH, INC (0001382574) (Issuer)

      2/24/23 4:45:23 PM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • SEC Form 4: Peterson Michael L was granted 100,000 shares, increasing direct ownership by 528% to 118,940 units

      4 - TRxADE HEALTH, INC (0001382574) (Issuer)

      1/20/23 4:15:19 PM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • SEC Form 3: New insider Peterson Michael L claimed ownership of 18,940 shares

      3 - TRxADE HEALTH, INC (0001382574) (Issuer)

      1/6/23 7:59:27 PM ET
      $MEDS
      Other Pharmaceuticals
      Health Care
    • SEC Form 4: Newell A. Jeffrey was granted 79,062 shares

      4 - TRxADE HEALTH, INC (0001382574) (Issuer)

      12/30/22 7:50:52 PM ET
      $MEDS
      Other Pharmaceuticals
      Health Care